| Literature DB >> 22691623 |
Abstract
BACKGROUND: Low back pain (LBP) is common and costly and few treatments have been shown to be markedly superior to any other. Effort has been focused on stratifying patients to better target treatment. Recently the STarT Back Screening Tool (SBT) has been developed for use in primary care to enable sub grouping of patients based on modifiable baseline characteristics and has been shown to be associated with differential outcomes. In the UK the SBT is being recommended to assist in care decisions for those presenting to general practitioners with LBP. In the light of growing recommendation for widespread use of this tool, generalisability to other LBP populations is important. However, studies to date have focused only on patients attending physiotherapy whereas LBP patients seeking other treatment have not been investigated. AIMS: This study aims to investigate the utility of the SBT to predict outcomes in LBP patients presenting for chiropractic management.Entities:
Year: 2012 PMID: 22691623 PMCID: PMC3422208 DOI: 10.1186/2045-709X-20-17
Source DB: PubMed Journal: Chiropr Man Therap ISSN: 2045-709X
Figure 1Numbers in study at each follow up point in each Start Back Tool category.
Descriptive analysis of baseline variables across Start Back Tool (SBT) categories
| 45.4 (15.1) | 45.9 (15.0) | 45.8 (14.1) | |
| 54.8% | 52.7% | 50.5% | |
| 47.0% | 59.7% | 33.6% | |
| | 25.5% | 23.3% | 35.5% |
| | 6.0% | 10.9% | 12.1% |
| 41.1% | 41.1% | 38.3% | |
| 69.6% | 65.9% | 59.8% | |
| | 54.8% | 53.5% | 61.7% |
| | 14.3% | 14.0% | 7.5% |
| | 31.0% | 32.6% | 30.8% |
| 5 (4–7) | 7 (6–8) | 7 (6–9) | |
| 24 (14–33) | 36 (30–44) | 45 (34–54) | |
*P < 0.05 (Chi2 test for trend). **p < 0.001, (Kruskal-Wallis).
Pain, total BQ scores and proportion of subjects with a poor outcome across Start Back Tool (SBT) categories at 14, 30 and 90 days follow up
| 2 (1–3) | 10 (3–18) | 1 (1–3) | 6 (2–14) | 1 (1–2) | 5 (0–15) | |
| 2 (1–5) | 12 (3–26) | 2 (1–4) | 10 (5–21) | 1 (1–4) | 8 (0–18) | |
| 3 (1–5) | 20 (8–33) | 2 (0–3) | 6 (2–20) | 2 (0–3) | 10 (3–22) | |
**p < 0.001, (Kruskal-Wallis), ¥Patients Global Impression of Change < 6.
Figure 2Resdualisedchange scores compared between SBT risk groups for Total BQ (a) and Pain (b).
Proportions (%) of patients with a poor outcome across Start Back Tool categories defined by cut-off points for each outcome
| Low | 36.1 (35) | 29.1 (16) | 18.2 (12) |
| Medium | 30.3 (23) | 29.5 (13) | 27.5 (14) |
| High | 33.9 (21) | 28.1 (9) | 27.3 (9) |
| Low | 37.9 (33) | 24.0 (12) | 23.0 (14) |
| Medium | 24.7 (18) | 26.2 (11) | 24.5 (12) |
| High | 32.8 (19) | 32.3 (10) | 18.8 (6) |
| Low | 28.9 (24) | 20.4 (10) | 14.0 (8) |
| Medium | 29.4 (20) | 25.6 (10) | 19.6(9) |
| High | 41.5 (22) | 29.0 (9) | 18.2 (6) |
PGIC = Patient Global Impression of Change; NRS = Numerical Rating Scale; BQ = Bournemouth Questionnaire.
Predicting poor outcome (PGIC) at 14, 30 and 90 days for the whole group (n = 404)
| 1.0 | 1.0 | 1.0 | |
| 0.8 (0.4 to 1.5) | 1.0 (0.4 to 2.4) | 1.7 (0.7 to 4.1) | |
| 0.9 (0.5 to 1.8) | 0.9 (0.4 to 2.5) | 1.7 (0.6 to 4.5) |
PGIC = Patient Global Impression of Change; SBT = Start Back Tool.
Predicting poor outcome (PGIC) at 14, 30 and 90 days follow up split by gender
| 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | |
| 1.2 (0.5 to 3.0) | 0.5 (0.2 to 1.3) | 0.7 (0.2 to 2.7) | 1.2 (0.3 to 4.0) | 3.0 (0.9 to 10.0) | 0.9 (0.2 to 3.3) | |
| 1.8 (0.7 to 5.0) | 0.5 (0.2 to 1.2) | 0.7 (0.2 to 3.2) | 1.0 (0.3 to 4.1) | 3.0 (0.6 to 16.0) | 1.1 (0.3 to 4.0) | |
PGIC = Patient Global Impression of Change; SBT = Start Back Tool.
Predicting poor outcome (Change in pain ≤ 2 points) at 14, 30 and 90 days
| 1.0 | 1.0 | 1.0 | |
| 0.5 (0.3 to 1.1) | 1.1 (0.4 to 2.9) | 1.1 (0.4 to 2.6) | |
| 0.8(0.4 to 1.6) | 1.5 (0.5 to 4.1) | 0.8 (0.3 to 2.2) |
SBT = Start Back Tool.
Predicting poor outcome (Change in total BQ ≤47%) at 14, 30 and 90
| 1.0 | 1.0 | 1.0 | |
| 1.0 (0.5 to 2.1) | 1.3 (0.5 to 3.6) | 1.5 (0.5 to 4.2) | |
| 1.7 (0.8 to 3.6) | 1.6 (0.6 to 4.5) | 1.4 (0.4 to 4.3) |
BQ = Bournemouth Questionnaire; SBT = Start Back Tool.
Adjusted models for predicting poor outcome (PGIC) at 14, 30 and 90 days follow up
| Pain for >30 days in year | 3.2 (1.9 to 5.6) | 0.26 | 90/25 | |
| Pain (for every 1 point increase) | 0.8 (0.8 to 0.9) | | | |
| Duration | | 0.32 | 92/29 | |
| < 1 month | 1.0 | | | |
| 1–3 months | 5.6 (1.8 to 17.0) | | | |
| >3 months | 2.4(1.1 to 5.5) | | | |
| | | 0.45 | 94/23 | |
| Duration | | | | |
| < 1 month | 1.0 | | | |
| 1–3 months | 9.3 (3.0 to 29.0) | | | |
| >3 months | 3.0(1.3 to 7.0) |
* = variance explained by model; sn = sensitivity; sp = specificity; PGIC = Patient Global Impression of Change.